← SynDRA
DARAPLADIB
SynDRA canonical compound SYN0000011 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | PLA2G7 |
| Mechanism of action | Phospholipase inhibitor |
All known targets
Mechanisms of action (all sources)
- Phospholipase inhibitor
- PLA2G7 INHIBITOR
- LDL-associated phospholipase A2 inhibitor
- PLA2G1B MODULATOR
Drug classes
- Phospholipase A2 Inhibitors
Cross-references
Synonyms
- SB-480848
- SB 480848
- Darapladib (USAN)
- Darapladib (SB-480848)
- N-(2-(Diethylamino)ethyl)-2-(2-((4-fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)-N-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide
- UI1U1MYH09
- CHEMBL204021
- N-[2-(Diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-cyclopentapyrimidine-1-acetamide
- 1H-Cyclopentapyrimidine-1-acetamide, N-(2-(diethylamino)ethyl)-2-(((4-fluorophenyl)methyl)thio)-4,5,6,7-tetrahydro-4-oxo-N-((4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)methyl)-
- N-[2-(Diethylamino)ethyl]-2-{2-[(4-Fluorobenzyl)sulfanyl]-4-Oxo-4,5,6,7-Tetrahydro-1h-Cyclopenta[d]pyrimidin-1-Yl}-N-{[4'-(Trifluoromethyl)biphenyl-4-Yl]methyl}acetamide
- Darapladib [USAN:INN]
- UNII-UI1U1MYH09
- SB480848
- DARAPLADIB [MI]
- DARAPLADIB [INN]
- DARAPLADIB [JAN]
- Darapladib (JAN/USAN)
- DARAPLADIB [USAN]
- DARAPLADIB [WHO-DD]
- Darapladib; SB-480848
- MLS006010424
- GTPL6696
- SCHEMBL2742709
- DTXSID70189073
- HMS3653B13
- HMS3744E13
- BCP04908
- EX-A2245
- ZINC3842798
- BDBM50125265
- FD5008
- MFCD18251452
- s7520
- AKOS025290042
- BCP9000585
- CCG-270349
- CS-1035
- DB06311
Look up DARAPLADIB in the interactive SynDRA portal →